Polo kinase function and the treatment of drug resistant tumours.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/525447

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Death from cancer often results from tumours becoming resistant to chemotherapy drugs. Some cancers, particularly the common bowel cancers, have high levels of drug resistance that seem to be caused by loss of the controls that act during normal cell division. We will assess whether a recently developed therapeutic approach will kill these drug resistant cancer cells and identify factors that can be targeted to increase the potency and specificity of the therapy.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $559,894.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cell Development (Incl. Cell Division And Apoptosis)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Drosophila melanogaster | cancer biology | cell biology | cell cycle | cell cycle regulation | cytoskeleton | drug resistance in cancer | molecular genetics | novel anticancer agents

Related Links